Coherus Oncology, Inc. (CHRS) on Monday reported a loss of $37.6 million in its fourth quarter. The Redwood City, California-based company said it had a loss of 31 cents per share. Losses, adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results